Maraganore, Meanwell Launch Corsera, Their Third Act In Cardiovascular Disease

Start-Up Has Predictive Test, Once-Yearly RNAi Drug

 
• By Mandy Jackson
  
Corsera's cardiovascular risk prediction tool pairs AI with genetic and other patient data (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business